R Fernández-de-Misa, M Montes-de-Oca, I Loizate, N Hernández-Hernández
{"title":"Multiple Basal Cell Carcinomas. Timeline and Underlying Risk Factors.","authors":"R Fernández-de-Misa, M Montes-de-Oca, I Loizate, N Hernández-Hernández","doi":"10.1016/j.ad.2024.10.070","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Between 29% and 53% of the patients who develop basal cell carcinoma (BCC) will develop new BCCs.</p><p><strong>Objectives: </strong>Current objectives are to analyze the proportion and basic characteristics of patients who develop BCC> 1, to delineate the concept of multiple BCC (mBCC) and be able to identify the factors associated with its development, and analyze its timeframe.</p><p><strong>Patients and method: </strong>We conducted a retrospective observational study including all patients diagnosed with sporadic BCC from January 1<sup>st</sup>, 2014 through December 31<sup>st</sup>, 2014 at a tertiary referral center. Data included dates of BCCs, gender, age and histology of the first BCC, and the presence of BCC> 1 at the initial appointment (cluster<sup>+</sup>). mBCC was defined as a patient who developed a series of BCCs> the 75<sup>th</sup> percentile of the series.</p><p><strong>Results: </strong>A total of 758 patients (51.2% men), were included. After a median follow-up of 100 months, 52.8% of the patients developed BCC> 1. The 75<sup>th</sup> percentile of the number of BCCs was 3. Factors associated to mBCCs included being cluster<sup>+</sup> (OR, 5.6; 95%CI, 3.2 - 9.7), being men (OR, 3.1; 95%CI, 2.0 - 4.8) and diagnosed with the first BCC between ages of 50 and 80 years (OR, 2.1; 95%CI, 1.3 - 3.5). After 5 years, 54% of patients exhibiting these 3 factors developed mBCC. The estimated median time to mBCC was 38.00 months (95%CI, 0 - 79.71).</p><p><strong>Conclusions: </strong>A quarter of patients who Exhibit 1 BCC eventually develop 4 or more BCCs. Analyzing routine parameters may help identify individuals at a higher risk of developing mBCC and predict its timeframe.</p>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Actas dermo-sifiliograficas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ad.2024.10.070","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Between 29% and 53% of the patients who develop basal cell carcinoma (BCC) will develop new BCCs.
Objectives: Current objectives are to analyze the proportion and basic characteristics of patients who develop BCC> 1, to delineate the concept of multiple BCC (mBCC) and be able to identify the factors associated with its development, and analyze its timeframe.
Patients and method: We conducted a retrospective observational study including all patients diagnosed with sporadic BCC from January 1st, 2014 through December 31st, 2014 at a tertiary referral center. Data included dates of BCCs, gender, age and histology of the first BCC, and the presence of BCC> 1 at the initial appointment (cluster+). mBCC was defined as a patient who developed a series of BCCs> the 75th percentile of the series.
Results: A total of 758 patients (51.2% men), were included. After a median follow-up of 100 months, 52.8% of the patients developed BCC> 1. The 75th percentile of the number of BCCs was 3. Factors associated to mBCCs included being cluster+ (OR, 5.6; 95%CI, 3.2 - 9.7), being men (OR, 3.1; 95%CI, 2.0 - 4.8) and diagnosed with the first BCC between ages of 50 and 80 years (OR, 2.1; 95%CI, 1.3 - 3.5). After 5 years, 54% of patients exhibiting these 3 factors developed mBCC. The estimated median time to mBCC was 38.00 months (95%CI, 0 - 79.71).
Conclusions: A quarter of patients who Exhibit 1 BCC eventually develop 4 or more BCCs. Analyzing routine parameters may help identify individuals at a higher risk of developing mBCC and predict its timeframe.
期刊介绍:
Actas Dermo-Sifiliográficas, publicación Oficial de la Academia Española de Dermatología y Venereología, es una revista de prestigio consolidado. Creada en 1909, es la revista mensual más antigua editada en España.En 2006 entró en Medline, y hoy resulta imprescindible para estar al día sobre la dermatología española y mundial.